Author:
Pradhan Rajesh,Pandey Meghna,Hejmady Siddhanth,Taliyan Rajeev,Singhvi Gautam,Dubey Sunil K.,Dubey Sachin
Reference134 articles.
1. McCamish M. Yoon W. and McKay J. (2016). Biosimilars: biologics that meet patients' needs and healthcare economics.Am. J. Manag. Care22 (13 Suppl.): S439–S442.http://www.ncbi.nlm.nih.gov/pubmed/28719221.
2. U.S. FDA. Drugs@FDA: FDA-Approved Drugs.https://www.accessdata.fda.gov/scripts/cder/daf/index.Cfm?event=overview.process&ApplNo=021409(accessed Apr. 21 2020).
3. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules
4. Building better monoclonal antibody-based therapeutics
5. Paul Ehrlich's Magic Bullets